| Literature DB >> 22696468 |
Thilo Kähne1, Angela Kolodziej, Karl-Heinz Smalla, Elke Eisenschmidt, Utz-Uwe Haus, Robert Weismantel, Siegfried Kropf, Wolfram Wetzel, Frank W Ohl, Wolfgang Tischmeyer, Michael Naumann, Eckart D Gundelfinger.
Abstract
Changes in synaptic efficacy underlying learning and memory processes are assumed to be associated with alterations of the protein composition of synapses. Here, we performed a quantitative proteomic screen to monitor changes in the synaptic proteome of four brain areas (auditory cortex, frontal cortex, hippocampus striatum) during auditory learning. Mice were trained in a shuttle box GO/NO-GO paradigm to discriminate between rising and falling frequency modulated tones to avoid mild electric foot shock. Control-treated mice received corresponding numbers of either the tones or the foot shocks. Six hours and 24 h later, the composition of a fraction enriched in synaptic cytomatrix-associated proteins was compared to that obtained from naïve mice by quantitative mass spectrometry. In the synaptic protein fraction obtained from trained mice, the average percentage (±SEM) of downregulated proteins (59.9 ± 0.5%) exceeded that of upregulated proteins (23.5 ± 0.8%) in the brain regions studied. This effect was significantly smaller in foot shock (42.7 ± 0.6% down, 40.7 ± 1.0% up) and tone controls (43.9 ± 1.0% down, 39.7 ± 0.9% up). These data suggest that learning processes initially induce removal and/or degradation of proteins from presynaptic and postsynaptic cytoskeletal matrices before these structures can acquire a new, postlearning organisation. In silico analysis points to a general role of insulin-like signalling in this process.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22696468 PMCID: PMC3509369 DOI: 10.1002/pmic.201100669
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984
Proteomics summary
| Step | Number/factor | Samples cumulative |
|---|---|---|
| Time points | 2 | 2 |
| Brain areas | 4 | 8 |
| Replicates | 4 | 32 |
| Digests (Tryp/GluC) | 2 | 64 |
| Peptide fractions | 20 | 1280 |
| LC-MS/MS runs/fraction | 1 | 1280 |
Score = Mowse score [70].
Pairwise comparison of treatments
| 95% confidence interval for difference | |||||||
|---|---|---|---|---|---|---|---|
| Treatment | Mean | Mean | |||||
| (I) | (J) | (I) | (J) | difference (I−J) | Lower bound | Upper bound | |
| FS | TC | 0.481 | 0.463 | 0.018 | 0.084 | −0.002 | 0.038 |
| AV | 0.294 | 0.187 | 0.116 | 0.257 | |||
| NV | 0.500 | −0.019 | −0.034 | −0.004 | |||
| TC | FS | 0.463 | 0.481 | −0.018 | 0.084 | −0.038 | 0.002 |
| AV | 0.294 | 0.169 | 0.095 | 0.242 | |||
| NV | 0.500 | −0.037 | −0.056 | −0.017 | |||
| AV | FS | 0.294 | 0.481 | −0.187 | −0.257 | −0.116 | |
| TC | 0.463 | −0.169 | −0.242 | −0.095 | |||
| NV | 0.500 | −0.206 | −0.280 | −0.131 | |||
| NV | FS | 0.500 | 0.481 | 0.019 | 0.004 | 0.034 | |
| TC | 0.463 | 0.037 | 0.017 | 0.056 | |||
| AV | 0.294 | 0.206 | 0.131 | 0.280 | |||
Based on estimated marginal means.
Repeated measurement ANOVA, adjustment for multiple comparisons: Bonferroni. Significant values (p < 0.05) in bold.
Figure 1Relative synaptic protein abundance profiles of all experimental groups. Mean values of quantifiable proteins [AV/NV (blue), FS/NV (red) and TS/NV (green)] derived from the striatum (STR), hippocampus (HIP), frontal cortex (FC), and auditory cortex (AC) 6 h or 24 h after behavioural experiments have been sorted according to the size and plotted. Note the prominent downregulation within the trained group (AV) in comparison to the control groups (FS, TS). The numbers and percentage of up and downregulated proteins within the four groups are indicated close to the graphs. Abundance values within a regulation threshold of 10% are excluded from plotting and calculation.
Avoidance conditioning-induced regulation of protein abundances in synaptic cytomatrices
| Swissprot ID | Gene description | Brain region | Time point | Regulation | ||
|---|---|---|---|---|---|---|
| AV/NV | FS/NV | TS/NV | ||||
| BSN_MOUSE | Protein bassoon | STR | 6 h | 0.52 | 0.57 | 0.72 |
| DYH5_MOUSE | Dynein heavy chain 5, axonemal | FC | 24 h | 0.66 | 1.08 | 1.02 |
| DYH8_MOUSE | Dynein heavy chain 8, axonemal | STR | 24 h | 0.64 | 0.89 | 0.89 |
| MACF1_MOUSE | Microtubule-actin cross-linking factor 1 | HIP | 24 h | 0.55 | 1.18 | 0.74 |
| MAP1A_MOUSE | Microtubule-associated protein 1A | FC | 24 h | 0.48 | 1.06 | 0.84 |
| MY18A_MOUSE | Myosin-XVIIIa | AC | 24 h | 0.57 | 1.01 | 1.45 |
| MYO5A_MOUSE | Myosin-Va | AC | 6 h | 0.65 | 1.55 | 1.12 |
| MYO5A_MOUSE | Myosin-Va | AC | 24 h | 0.49 | 0.95 | 0.47 |
| NFH_MOUSE | Neurofilament heavy polypeptide | AC | 24 h | 0.46 | 1.47 | 1.28 |
| NRAP_MOUSE | Nebulin-related-anchoring protein | FC | 24 h | 0.64 | 1.32 | 1.10 |
| OBSCN_MOUSE | Obscurin | HIP | 6 h | 0.54 | 1.42 | 1.13 |
| PCLO_MOUSE | Protein piccolo | FC | 24 h | 0.49 | 0.77 | 0.77 |
| PCLO_MOUSE | Protein piccolo | STR | 24 h | 0.50 | 0.86 | 0.79 |
| PLEC1_MOUSE | Plectin-1 | FC | 6 h | 0.75 | 1.01 | 0.75 |
| SPTA2_MOUSE | Spectrin alpha chain, brain | FC | 6 h | 0.68 | 1.03 | 1.12 |
| SPTB2_MOUSE | Spectrin beta chain, brain 1 | AC | 24 h | 0.59 | 0.88 | 0.70 |
| SPTB2_MOUSE | Spectrin beta chain, brain 1 | FC | 24 h | 0.59 | 1.45 | 1.56 |
| SPTB2_MOUSE | Spectrin beta chain, brain 1 | STR | 24 h | 0.48 | 0.79 | 0.66 |
| TITIN_MOUSE | Titin | AC | 6 h | 0.62 | 0.90 | 0.98 |
| TITIN_MOUSE | Titin | AC | 24 h | 0.54 | 1.03 | 0.94 |
| TITIN_MOUSE | Titin | FC | 6 h | 0.61 | 1.09 | 0.85 |
| TITIN_MOUSE | Titin | FC | 24 h | 0.57 | 0.98 | 0.88 |
| TITIN_MOUSE | Titin | HIP | 24 h | 0.67 | 1.04 | 0.97 |
| TITIN_MOUSE | Titin | STR | 6 h | 0.67 | 1.06 | 1.10 |
| TITIN_MOUSE | Titin | STR | 24 h | 0.60 | 0.93 | 0.83 |
| TPPP_MOUSE | Tubulin polymerisation-promoting protein | AC | 6 h | 0.44 | 1.36 | 0.83 |
| CO4A4_MOUSE | Collagen alpha-4(IV) chain | FC | 24 h | 0.75 | 1.00 | 0.86 |
| COBA2_MOUSE | Collagen alpha-2(XI) chain | HIP | 24 h | 0.46 | 0.81 | 0.71 |
| COGA1_MOUSE | Collagen alpha-1(XVI) chain | FC | 6 h | 0.63 | 0.81 | 0.60 |
| HRBL_MOUSE | HIV-1 Rev-binding protein-like protein | AC | 24 h | 0.60 | 0.97 | 0.95 |
| HRBL_MOUSE | HIV-1 Rev-binding protein-like protein | FC | 6 h | 0.64 | 0.87 | 0.89 |
| HRBL_MOUSE | HIV-1 Rev-binding protein-like protein | HIP | 24 h | 0.67 | 0.91 | 0.78 |
| HRBL_MOUSE | HIV-1 Rev-binding protein-like protein | STR | 24 h | 0.79 | 0.99 | 0.88 |
| U119B_MOUSE | Protein unc-119 homolog B | STR | 6 h | 0.66 | 0.94 | 0.94 |
| U119B_MOUSE | Protein unc-119 homolog B | STR | 24 h | 0.59 | 0.62 | 0.73 |
| CBL_MOUSE | E3 ubiquitin-protein ligase CBL | AC | 6 h | 0.73 | 1.00 | 1.04 |
| CBL_MOUSE | E3 ubiquitin-protein ligase CBL | AC | 24 h | 0.64 | 0.98 | 0.96 |
| CBL_MOUSE | E3 ubiquitin-protein ligase CBL | FC | 24 h | 0.64 | 1.08 | 0.92 |
| CBL_MOUSE | E3 ubiquitin-protein ligase CBL | STR | 6 h | 0.70 | 0.87 | 0.97 |
| GAS8_MOUSE | Growth arrest-specific protein 8 | FC | 24 h | 0.68 | 0.95 | 0.86 |
| H2AW_MOUSE | Core histone macro-H2A.2 | STR | 24 h | 0.49 | 0.58 | 1.32 |
| H4_MOUSE | Histone H4 | AC | 6 h | 0.64 | 1.02 | 0.85 |
| H4_MOUSE | Histone H4 | AC | 24 h | 0.67 | 0.87 | 0.82 |
| H4_MOUSE | Histone H4 | FC | 24 h | 0.51 | 0.97 | 0.99 |
| H4_MOUSE | Histone H4 | STR | 24 h | 0.52 | 1.00 | 0.81 |
| HNRPM_MOUSE | Heterogeneous nuclear ribonucleoprotein M | FC | 6 h | 0.71 | 1.28 | 1.10 |
| HNRPM_MOUSE | Heterogeneous nuclear ribonucleoprotein M | STR | 6 h | 0.45 | 0.78 | 0.70 |
| LSD1_MOUSE | Lysine-specific histone demethylase 1 | STR | 24 h | 0.44 | 0.66 | 0.61 |
| NUCL_MOUSE | Nucleolin | STR | 24 h | 0.47 | 0.64 | 0.70 |
| PIN4_MOUSE | Peptidyl-prolyl cis-trans isomerase | STR | 6 h | 0.73 | 0.94 | 1.05 |
| SLTM_MOUSE | SAFB-like transcription modulator | FC | 24 h | 0.67 | 0.82 | 0.85 |
| SRP68_MOUSE | Signal recognition particle 68 kDa protein | AC | 6 h | 0.67 | 0.91 | 0.95 |
| ROCK2_MOUSE | Rho-associated protein kinase 2 | FC | 24 h | 0.35 | 0.47 | 0.74 |
a) Mean protein abundances in PSD-enriched fractions derived from trained mice (AV), foot-shock controls (FS), and tone controls (TS) normalised to the corresponding values from naïve mice (NV).
p < 0.05, significantly different from 1 (one sample t-test; 3≤n≤4 per group).
Figure 2Quantitative immunoblot analysis for HRBL and CBL in trained versus naïve animals. (A) Comparative Western blots of PSD-enriched fractions from striatum (STR), hippocampus (HIP) and frontal cortex (FC) from aversively trained (AV) and naïve (NV) mice probed with antibodies against the ArfGAP HRBL and the E3 ubiquitin ligase CBL. (B) Quantification of the data in panel A. In three cases, the observed downregulation is significant (Student’s t-test).